Amylase, Lipase, Protease

KREON 25.000 U cápsulas duras gastrorresistentes

18000 U + 25000 U + 1000 U cápsula duraSpainMarketedAuthorised 18 Apr 2001

In other countries

The same active substances on other registers, the same brand first.

CotazymCanada · 40000 UNIT + 10000 UNIT + 35000 UNIT · Capsule (Immediate-Release) · Organon Canada INC.Same form
Cotazym Ecs 20Canada · 100000 UNIT + 25000 UNIT + 100000 UNIT · Capsule (Delayed-Release) · Organon Canada INC.Same form
Cotazym Ecs 8Canada · 42000 UNIT + 10800 UNIT + 45000 UNIT · Capsule (Delayed-Release) · Organon Canada INC.Same form
PancreaseBrazil · Janssen-Cilag Farmacêutica LtdaSame substance
PanzytratBrazil · Abbott Laboratórios do Brasil LtdaSame substance

Packs

Pack	Code	Status
KREON 25.000 U cápsulas duras gastrorresistentes, 100 cápsulas	672971
KREON 25.000 U cápsulas duras gastrorresistentes, 50 cápsulas	672974

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Amylase, Lipase, Protease

KREON 25.000 U cápsulas duras gastrorresistentes

18000 U + 25000 U + 1000 U cápsula duraSpainMarketedAuthorised 18 Apr 2001

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
KREON 25.000 U cápsulas duras gastrorresistentes, 100 cápsulas	672971
KREON 25.000 U cápsulas duras gastrorresistentes, 50 cápsulas	672974

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Amylase, Lipase, Protease
Strength: 18000 U + 25000 U + 1000 U
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 18 Apr 2001
Registration: 63832
Marketing authorisation holder: Viatris Healthcare Limited
Procedure: National, MRP or DCP
Supply: Diagnóstico Hospitalario

Spain